Sun Pharma Appoints Kirti Ganorkar as Managing Director; Dilip Shanghvi to Continue as Executive Chairman

Sun Pharma appoints Kirti Ganorkar as MD, succeeding founder Dilip Shanghvi from September 1, 2025.

Simantini Singh Deo | Jun 15, 2025

Inside The Mind Of A Vaccine Manufacturing Leader: Rakesh Kumar Sinha Of Biological E Shares Insights On Quality, Leadership, And Innovation

Podcast with Rakesh Kumar Sinha on leadership, quality, and purpose at Biological E.

Simantini Singh Deo | Jun 14, 2025

AI in Pharma

Merck Begins Global Phase 3 Trial For Investigational Dengue Vaccine

Merck begins Phase 3 trial of V181 dengue vaccine, aiming for single-dose protection across all four serotypes.

Vaibhavi M. | Jun 13, 2025

Novo Nordisk Advances Subcutaneous And Oral Amycretin to Phase 3 for Obesity Management

Novo Nordisk to advance subcutaneous and oral amycretin into Phase 3 trials for weight management.

Vaibhavi M. | Jun 13, 2025

Novartis’ Fabhalta® Delivers Sustained Efficacy And Safety In PNH Patients Switching from Anti-C5 Therapies

Novartis reports strong Phase IIIB results for Fabhalta in PNH patients switching from anti-C5 therapies.

Vaibhavi M. | Jun 13, 2025

Starton Therapeutics Opens Enrollment For Phase 2a Trial Of STAR-LLD, A Continuous Low-Dose Lenalidomide Therapy For Multiple Myeloma

Starton begins Phase 2a trial of STAR-LLD in multiple myeloma with first patients enrolled in Ohio and North Carolina.

Simantini Singh Deo | Jun 13, 2025

BioNTech To Acquire CureVac In Public Share Offer, Aims To Expand mRNA Innovation Powerhouse

BioNTech to acquire CureVac in $1.25B all-stock deal to strengthen mRNA cancer pipeline.

Simantini Singh Deo | Jun 13, 2025